KAPS vs OPRA: What Changed, and What It Means for Your Preparation

The short answer

KAPS (Knowledge Assessment of Pharmaceutical Sciences) is no longer the assessment the APC uses for the overseas-trained pharmacist pathway. OPRA replaced it. If you are registering now, OPRA is the exam you will sit, and preparation material written for OPRA is what you want.

One caveat worth taking seriously: exactly which exam applies to you can depend on when you registered and where you are in the pathway. Transition arrangements are the APC's to define, not ours, so confirm your own position with the APC directly rather than with a coaching site or a candidate group — including this page.

KAPS vs OPRA at a glance

What actually changed

The differences that matter for how you prepare, rather than the ones that only matter on paper:

• Two papers became one. KAPS used two papers; OPRA is a single 120-question, 150-minute examination with no scheduled break.
• The weighting moved towards therapeutics. The APC describes the redesign as giving the exam “a stronger focus on therapeutics and the application of knowledge to align with evolving pharmacy practice within Australia.” A study plan built around the old KAPS specification's priorities should be rebalanced accordingly.
• The content areas were reorganised into five weighted domains — see the full syllabus breakdown for what each contains — but OPRA still tests a substantial amount of recall. The APC's published cognitive mix is approximately 55% recall, 30% comprehension and 15% application, so don't over-correct by preparing only with long clinical scenarios.
• Question selection and scoring were revised: OPRA uses scaled scoring, with the passing standard set through psychometric standard-setting. The APC states your result is based on overall performance across the entire exam, not on separate domain pass marks — content-area feedback is provided to help you identify areas for further development, but it isn't what determines whether you pass.

Is your KAPS study wasted?

No, and this is the part people worry about most. Pharmacology, therapeutics, pharmacokinetics, calculations, medicinal chemistry — the underlying pharmacy science you studied for KAPS remains relevant to OPRA, even though the assessment itself has changed. If you have been working through that content, you have been building the right foundation.

What needs revisiting is narrower than it feels. Anything tied to the two-paper structure or the old timing needs to be re-rehearsed against the current format. Anything weighted for the old content split needs re-balancing towards therapeutics. And anything written against Australian guidance that has since been superseded needs replacing — that is true of any old material, KAPS-era or not, and it is a particular risk with older question sets circulating in candidate groups.

The KAPS-era habits that cost marks on OPRA

• Studying pharmaceutical chemistry to KAPS depth while leaving therapeutics until last — the weighting now runs the other way.
• Practising untimed. A single shorter paper punishes poor pacing more than two papers did; rehearse it as a full timed mock, not as a question set.
• Relying on recall practice alone. Recall matters — the APC's own published mix puts around 55% of OPRA questions at that level — but preparation also needs to cover comprehension and application, which together make up the other 45%.
• Trusting old recalled question sets. See why recalled questions are not a safe substitute — stale guidance and unverified answer keys are the norm in them.

Looking for a KAPS question bank or KAPS mock exam?

If you're preparing for OPRA, an old KAPS-specific bank is not the best match for the current assessment — what you want is the OPRA equivalent. Our bank is 2,524 original OPRA-style questions across the five domains, each with option-by-option reasoning and a cited Australian source, and our mock exam runs the real format: 120 questions in 150 minutes, sampled to approximately match the APC's published domain weightings and scored per domain against ClinicalStem's own 70% practice benchmark.

If you are specifically after the pharmaceutical-sciences depth that KAPS was known for, it is still examinable — biomedical sciences, medicinal chemistry and biopharmaceutics, and pharmacokinetics together account for about 40% of the published content weighting. It is simply no longer the centre of gravity.

If you're one of the candidates still sitting KAPS

Then be straight with yourself about what we are: ClinicalStem is built for OPRA. Our question bank is weighted to the APC's current OPRA content areas and our mocks run the OPRA format, so if you are sitting the old two-paper KAPS, this is not the right tool for you and we would rather say so than take the subscription.

The overlap is real — the science is the same and the free topic guides will still be useful to you at no cost — but the timing rehearsal and the domain weighting would be training you for the wrong paper. Confirm which exam applies to you with the APC before you spend money with anyone, us included.

Where to start if you're switching over

Re-baseline before you re-plan. Sit a timed mock early — not to score well, but to get a per-domain picture of where a KAPS-shaped study plan has left you thin. Let the result decide where to focus rather than assuming: therapeutics is the domain the redesign weighted up the most, so it's a reasonable first guess, but your own baseline is what should actually direct your study time.

From there, the study method guide covers how to sequence the work and how long to leave, and the syllabus tells you what sits inside each domain so you can target the gap rather than restarting from scratch. You are further along than the name change makes it feel.